This announcement is a separate document:
信達生物：建議授出購回股份及發行新股份的一般授權、建議重選退任董事、建議續聘外聘核數師、建議根據2020年受限制股份計劃向董事授出受限制股份、建議採納新組織章程及組織章程細則及股東週年大會通告
INNOVENT BIO: PROPOSED GRANTING OF GENERAL MANDATES TO BUY BACK SHARES AND TO ISSUE NEW SHARES, PROPOSED RE-ELECTION OF THE RETIRING DIRECTORS, PROPOSED RE-APPOINTMENT OF THE EXTERNAL AUDITOR, PROPOSED GRANTS OF RESTRICTED SHARES TO DIRECTORS UNDER THE 202
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.